✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Gujarat Inject (Kerala) Ltd.

GUJINJEC

Market Cap
₹27 Cr.
P/E
27.88

Gujarat Inject (Kerala) Ltd.

  • Guj. Inject (Kerala)
  • Kabra Drugs
  • Vineet Laboratories
FAQs on Gujarat Inject (Kerala) Ltd. Shareprice

Guj. Inject (Kerala) has given better returns compared to its competitors.
Guj. Inject (Kerala) has grown at ~54.65% over the last 2yrs while peers have grown at a median rate of 9.0%

Guj. Inject (Kerala) is not expensive.
Latest PE of Guj. Inject (Kerala) is 27.88, while 3 year average PE is 133.
Also latest EV/EBITDA of Guj. Inject (Kerala) is 26.04 while 3yr average is 92.04.

View FAQ's On Business
Growth Table
  • Gujarat Inject (Kerala) Ltd.
  • Kabra Drugs
  • Vineet Laboratories
Balance Sheet
  • Gujarat Inject (Kerala) Ltd.
  • Kabra Drugs
  • Vineet Laboratories
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Gujarat Inject (Kerala) Ltd.
  • Kabra Drugs
  • Vineet Laboratories
Cash Flow
  • Gujarat Inject (Kerala) Ltd.
  • Kabra Drugs
  • Vineet Laboratories
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Gujarat Inject (Kerala) Ltd.
  • Kabra Drugs
  • Vineet Laboratories
Quarterly Results
  • Gujarat Inject (Kerala) Ltd.
  • Kabra Drugs
  • Vineet Laboratories
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Gujarat Inject (Kerala) Ltd. Financials

Guj. Inject (Kerala) balance sheet is weak and might have solvency issues

Yes, The net debt of Guj. Inject (Kerala) is increasing.
Latest net debt of Guj. Inject (Kerala) is -₹0.15 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹5.73 Crs.

Yes, profit is increasing.
The profit of Guj. Inject (Kerala) is ₹0.98 Crs for TTM, ₹0.08 Crs for Mar 2024 and ₹0.04 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Guj. Inject (Kerala) latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech